News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Quintiles Transnational Corp. May Trump PAREXEL International’s ClinPhone Inc. Offer
June 13, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, June 13 (Reuters) - Quintiles Transnational, a U.S.-based pharmaceutical services company, is weighing a counterbid for Britain's Clinphone that would trump an $182 million agreed bid from biotech firm Parexel International.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
Rare diseases
Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M
August 13, 2026
·
2 min read
·
Tristan Manalac
Bankruptcy
Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale
August 13, 2026
·
2 min read
·
Tristan Manalac
Insights
The Italian inflection point: Clinical strength, culture and capital
August 13, 2026
·
1 min read
·
Jennifer C. Smith-Parker
IPO
2026 IPO stock tracker: How newly public biotechs are performing
August 12, 2026
·
1 min read
·
Gabrielle Masson